SEOM clinical guidelines in early stage breast cancer (2018)

Ayala de la Peña, F. ; Andrés, R. (Universidad de Zaragoza) ; Garcia-Sáenz, J.A. ; Manso, L. ; Margelí, M. ; Dalmau, E. ; Pernas, S. ; Prat, A. ; Servitja, S. ; Ciruelos, E.

Resumen: Breast cancer is the most common cancer in women in our country and it is usually diagnosed in the early and potentially curable stages. Nevertheless, around 20–30% of patients will relapse despite appropriate locoregional and systemic therapies. A better knowledge of this disease is improving our ability to select the most appropriate therapy for each patient with a recent diagnosis of an early stage breast cancer, minimizing unnecessary toxicities and improving long-term efficacy.

Idioma: Inglés

DOI: 10.1007/s12094-018-1973-6

Año: 2018

Publicado en: Clinical and Translational Oncology 21 (2018), 18 - 30
ISSN: 1699-048X

Factor impacto JCR: 2.441 (2018)

Categ. JCR: ONCOLOGY rank: 153 / 229 = 0.668 (2018) - Q3 - T3

Factor impacto SCIMAGO: 0.883 - Cancer Research (Q1) - Oncology (Q1) - Medicine (miscellaneous) (Q1)

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)